Dr John Ostrominski presents the Clinical Picture, 'Pulmonary embolism with thrombus-in-transit across a patent foramen ovale', published in The Lancet in September 2023.

Scientists around the world speak to the importance of conducting representative research and show how when people can't make it to a study, the study needs to come to them. With new technologies and novel approaches, it is becoming increasingly evident that the way we conduct research can matter as much as the research itself.

The Lancet Group for Racial Equity (GRacE) was founded in June 2020 following the murder of George Floyd and Black Lives Matter protests. Three years on, this new video platforms the group’s purpose, vision, and work to date. Spotlighting GRacE represents an important part of our ongoing commitment to advance equity, diversity, and inclusion within The Lancet Group, medical publishing, and global health. GRacE members communicate why such efforts are crucial for the best research and for improving health outcomes among minoritised populations around the world.

The Lancet Group for Racial Equity (GRacE) was founded in June 2020 following the murder of George Floyd and Black Lives Matter protests. Three years on, this new video platforms the group’s purpose, vision, and work to date. Spotlighting GRacE represents an important part of our ongoing commitment to advance equity, diversity, and inclusion within The Lancet Group, medical publishing, and global health. GRacE members communicate why such efforts are crucial for the best research and for improving health outcomes among minoritised populations around the world.

Dr Brett Mansfield at the University of the Witwatersrand in Johannesburg, South Africa, presents the Clinical Picture, published in The Lancet in September 2023, entitled: Regression of cutaneous xanthomata in patient with homozygous familial hypercholesterolemia using novel therapies

Health and sustainability practitioners from different parts of the world discuss measures to decarbonise our hospitals and healthcare.

Dr. Roy Fleischmann from the University of Texas Southwestern Medical Center in Dallas, Texas, presents a study of multiple switches between the biosimilar adalimumab PF-06410293 and reference adalimumab in patients with active rheumatoid arthritis. The study was published in The Lancet Rheumatology in August 2023.

Dr Robert Spencer presents his Clinical Picture, published in The Lancet: Noisy breathing in a 2-month-old baby: a pulmonary artery sling

Health and sustainability practitioners from different parts of the world discuss measures to decarbonise our hospitals and healthcare.

Dr Vivian Szymczuk presents their Clinical Picture, Metaphyseal sclerosis in a child with a giant cell tumour treated with denosumab.

Dr Miles Kiernan at the Department of Ophthalmology, North Middlesex University Hospital NHS Trust, presents his Clinical Picture on hereditary gelsolin amyloidosis, published in The Lancet on 17 June 2023.

Dr James Harding presents the findings of their paper, published in The Lancet Oncology on 2 June 2023: Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZONBTC-01): a multicentre, single-arm, phase 2b study.

Prof Sumanta Kumar Pal and Prof Toni K Choueiri present the findings of their trial, published in The Lancet in June 2023: Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, openlabel, phase 3 trial

Dr Valéry Daubie and Dr Hussein Farhat present their Clinical Picture on 'Caution with refeeding in severe anorexia nervosa', published in The Lancet on 3 June 2023.

Dr Maël Richard presents his clinical picture on Diffuse myocardial calcifications following severe sepsis, published in The Lancet.

Prof Dr Andres Pichon-Riviere, Managing Director of the Institute for Clinical Effectiveness and Health Policy (IECS) in Buenos Aires, Argentina, presents the findings published in The Lancet Global Health on 16 May 2023: Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures

Prof Dr Andres Pichon-Riviere, Managing Director of the Institute for Clinical Effectiveness and Health Policy (IECS) in Buenos Aires, Argentina, presents the findings published in The Lancet Global Health on 16 May 2023: Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures

Dr. Roger Stupp and Dr. Adam M Sonabend present the findings of their paper, published in The Lancet Oncology on 2 May 2023: Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial

Experts from around the world speak on the importance of improving the Availability, Accessibility, Acceptability and Quality of healthcare for all, and share insights into their own efforts and experiences.

Morcellation bags contain both malignant and benign tumours.